O’Shannessy, D. J., Somers, E. B., Palmer, L. M., Thiel, R. P., Oberoi, P., Heath, R., & Marcucci, L. (2013). Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: Association to disease stage and grade and comparison to CA125 and HE4. BioMed Central.
Styl ChicagoO’Shannessy, Daniel J., Elizabeth B. Somers, Leslie M. Palmer, Robert P. Thiel, Pankaj Oberoi, Ryan Heath, a Lisa Marcucci. Serum Folate Receptor Alpha, Mesothelin and Megakaryocyte Potentiating Factor in Ovarian Cancer: Association to Disease Stage and Grade and Comparison to CA125 and HE4. BioMed Central, 2013.
Citace podle MLAO’Shannessy, Daniel J., et al. Serum Folate Receptor Alpha, Mesothelin and Megakaryocyte Potentiating Factor in Ovarian Cancer: Association to Disease Stage and Grade and Comparison to CA125 and HE4. BioMed Central, 2013.